I believe NEU has turned a corner in the past 3 months. 1) New MD and Chairman. Both with plenty of energy. I strongly believe Jon will be a much more consistent communicator to the market and will give much more regular updates. 2) Raising has allowed acceleration of NNZ 2591. This allows them to get on with it. They are pretty excited by the early modelling of this and looking at the mouse results, they look very interesting. A positive Phase 1 and Phase 2 following (hopefully) early 2021 will create an excellent news flow. 4) Trof is moving along. Acadia are saying they have protocols in place to continue the Trof Phase III and already patients are on Lilac. It seems that Acadia are now pushing through and I am hoping that they are seeing interesting results. 5) Register is cleaning up. New investors are onward and LW is out. This was done relatively cleanly. Regal is supposedly on and manipulating the share price but general thoughts on this forum is to reduce their entry. Which means unless you are trading out of them soon, they are accumulating because they believe the story. Of course it would be nice if there was more institutional support on the register and it was tighter but I think this will happen as we see further results and milestones.
Interesting future ahead
DYOR, Not investment advice.
NEU Price at posting:
$1.31 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)